Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum to "When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" [Bull. Cancer 109 (2022) 916-24].
Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van De Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V. Meert AP, et al. Among authors: gibelin a. Bull Cancer. 2023 Apr;110(4):467-468. doi: 10.1016/j.bulcan.2023.02.001. Epub 2023 Feb 17. Bull Cancer. 2023. PMID: 36805208 No abstract available.
When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Meert AP, Toffart AC, Picard M, Jaubert P, Gibelin A, Bauer P, Mokart D, Van De Louw A, Hatzl S, Moreno-Gonzales G, Rousseau-Bussac G, Bruneel F, Montini L, Moreau AS, Carpentier D, Seguin A, Hemelaar P, Azoulay E, Lemiale V. Meert AP, et al. Among authors: gibelin a. Bull Cancer. 2022 Sep;109(9):916-924. doi: 10.1016/j.bulcan.2022.04.014. Epub 2022 Jun 16. Bull Cancer. 2022. PMID: 35718570
ICU admission for solid cancer patients treated with immune checkpoint inhibitors.
Toffart AC, Meert AP, Wallet F, Gibelin A, Guisset O, Gonzalez F, Seguin A, Kouatchet A, Delaunay M, Debieuvre D, Duchemann B, Rousseau-Bussac G, Nyunga M, Grimaldi D, Levrat A, Azoulay E, Lemiale V. Toffart AC, et al. Among authors: gibelin a. Ann Intensive Care. 2023 Apr 18;13(1):29. doi: 10.1186/s13613-023-01122-z. Ann Intensive Care. 2023. PMID: 37072645 Free PMC article.
In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Luyt CE, Combes A, Amoura Z. Pineton de Chambrun M, et al. Among authors: gibelin a. Chest. 2020 May;157(5):1158-1166. doi: 10.1016/j.chest.2019.11.010. Epub 2019 Nov 26. Chest. 2020. PMID: 31783015 Free article.
CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission.
Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Demoule A, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Combes A, Luyt CE, Amoura Z; SAPHIR study group. Pineton de Chambrun M, et al. Among authors: gibelin a. J Autoimmun. 2019 Sep;103:102292. doi: 10.1016/j.jaut.2019.06.003. Epub 2019 Jun 26. J Autoimmun. 2019. PMID: 31253464
Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients.
Azoulay LD, Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle F, Raphalen JH, Troger A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Moyon Q, Luyt CE, Kerneis M, Combes A, Amoura Z. Azoulay LD, et al. Among authors: gibelin a. J Autoimmun. 2022 Dec;133:102908. doi: 10.1016/j.jaut.2022.102908. Epub 2022 Sep 18. J Autoimmun. 2022. PMID: 36126365
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A; ANTICOVID Investigators. Labbé V, et al. JAMA Intern Med. 2023 Jun 1;183(6):520-531. doi: 10.1001/jamainternmed.2023.0456. JAMA Intern Med. 2023. PMID: 36946232 Free PMC article.
Dialysis-induced hypereosinophilia in the ICU.
Desnos C, D'Huy A, Rech JS, Rafat C, Gibelin A. Desnos C, et al. Among authors: gibelin a. J Nephrol. 2023 Mar;36(2):311-313. doi: 10.1007/s40620-022-01495-7. Epub 2022 Nov 18. J Nephrol. 2023. PMID: 36396844 Free PMC article. No abstract available.
50 results